Science is interesting and good. Potential is good. Progress is ok, but unfortunately the presentations did not meet my expectations and being in the medical sciences field i have realistic expectations. So, I opted out (disclosure changed accordingly) and will keep a close eye on this in the next 12 month. Having said that, if one is a loyal shareholder and are supporting the company for perhaps also personsl reasons that are beyond funancial insentive, then IMO it is a stock worth holding long term.
Ann: Alterity Presents New Data on ATH434, page-5
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $2.613K | 525K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 81057309 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 21164963 | 22 |
View Market Depth
| Last trade - 13.43pm 20/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |